Your Article Summary
See Latest ArticlesFuture therapeutic targets in osteoporosis
Current Opinion in Rheumatology, 06/16/09
Deal C - This review discusses potential future advances in drug therapy for osteoporosis including novel antiresorptive and anabolic agents that may become available in the coming years.
Related Articles
Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09
Relevance Score: 93%
Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09
Relevance Score: 90%
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09
Relevance Score: 89%
A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts
Bone, 10/27/09
Relevance Score: 89%
Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09
Relevance Score: 89%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer
Best Practice & Research: Clinical Rheumatology, 12/07/09
Osteoporosis risk assessment and ethnicity
Journal of General Internal Medicine, 12/07/09
Pattern of Bone Mineral Density in Sickle Cell Disease Patients with the High-Hb F Phenotype
Acta Haematologica, 12/07/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Synvisc-One for the treatment of knee osteoarthritis
International Journal of Clinical Rheumatology, 12/07/09
Glenohumeral Chondrolysis After Shoulder Arthroscopy Associated With Continuous Bupivacaine Infusion
Arthroscopy, 12/04/09
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09